0000012239 false 0000012239 2023-05-01 2023-05-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 1, 2023

 

Dominari Holdings Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   000-05576   52-0849320

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

725 5th Avenue, 23rd Floor

New York, NY 10022

(703) 992-9325

(Address, including Zip Code and Telephone Number, including

Area Code, of Principal Executive Offices)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value   DOMH   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

  

Effective as of May 1, 2023 (the “Effective Date”), Matthew B. McCullough, 37, was appointed as the General Counsel of Dominari Holdings Inc. (the “Company”). Mr. McCullough has served as the Company’s outside legal counsel since January 1, 2023. Prior to joining the Company, Mr. McCullough was a corporate lawyer with Ellenoff Grossman & Schole LLP in New York, New York beginning in July 2015. In his prior role, his practice was focused on representing issuers, underwriters, placement agents, and institutional investors in debt and equity capital markets transactions. He received his Bachelor of Science in Business Administration with a concentration in Finance, cum laude, from Ramapo College of New Jersey. Mr. McCullough received his Juris Doctorate, cum laude, from Brooklyn Law School in 2013. He is admitted to practice law in the State of New York and is a member of the New York Bar Association. He has no family relationship with any of the executive officers or directors of the Company. There are no arrangements or understandings between Mr. McCullough and any other person pursuant to which he was appointed as an officer of the Company.

 

In accordance with the terms of Mr. McCullough’s Employment Agreement with the Company, dated as of May 1, 2023 (the “Employment Agreement”), he will serve as the Company’s General Counsel for an initial term of five (5) years. Mr. McCullough’s base salary is $350,000 per year, subject to regular annual review, payable in accordance with the standard payroll practices of the Company, and subject to all withholdings and deductions, as required by law. The Employment Agreement also provides for a grant of nonqualified stock options to him under and subject to the terms of the Company’s 2022 Equity Incentive Plan (the “2022 EIP”) to purchase shares of the Company’s common stock with a fair market value (as determined under the 2022 EIP) on the grant date of $100,000, on or before May 31, 2023. The options have not yet been granted. Upon grant, the options will vest in equal amounts over a period of three (3) years on the anniversary of the grant date, subject to certain rights of acceleration upon a change of control and as otherwise provided in the Employment Agreement. Mr. McCullough is also entitled to an annual bonus, as determined by the Company’s Compensation Committee, in its sole discretion. Annual bonuses and all stock-based compensation are subject to certain clawback rights as provided in the Employment Agreement.

 

In addition to the foregoing, within thirty (30) days of the Effective Date, Mr. McCullough will receive a payment of $100,000 in the form of a five-year annually amortizing loan with interest at the mid-term applicable federal rate (the “Loan Agreement”). All remaining payments under the Loan Agreement will become immediately due and payable in the event Mr. McCullough’s employment with the Company is terminated by him or the Company, either voluntarily or involuntarily, at any time prior to the loan having been paid in full. Concurrent with each monthly anniversary of the loan and provided that Mr. McCullough remains an employee of the Company at such time, he will receive a bonus payment equal to the current payment then owed under the Loan Agreement, less applicable withholding taxes.

 

Mr. McCullough is also entitled to the payment or reimbursement of all reasonable out-of-pocket expenses. and is also provided with all health and other benefits provided by the Company to its senior executive employees.

 

1

 

 

The Employment Agreement also provides for customary events of termination of employment and provides that in the event of termination as a result of Mr. McCullough’s death or disability, Mr. McCullough is entitled to severance consisting of (i) six (6) months of his then current base salary; (ii) payment on a pro-rated basis of an annual bonus for the year of termination (which shall be deemed to equal 50% of his then current base salary); (iii) any unpaid annual bonus earned for the prior year; and (iv) any other payments earned in connection with any bonus plan to which Mr. McCullough was a participant as of the date of death or disability. In the event of termination of Mr. McCullough’s employment (i) as a result of the non-renewal of the Employment Agreement by the Company at the end of the then current term, (ii) by Mr. McCullough, for Good Reason (as such term is defined in the Employment Agreement), or (iii) by the Company, without Cause (as such term is defined in the Employment Agreement), then Mr. McCullough is entitled to the same severance as provided above. Additionally, if termination is by Mr. McCullough, for Good Reason, or by the Company, without Cause, or upon a change in control, then all equity grants held by Mr. McCullough will immediately vest.

 

The above description of the Employment Agreement, the Loan Agreement, and the Bonus Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Employment Agreement, the Loan Agreement, and the Bonus Agreement filed herewith as Exhibit 10.1, Exhibit 10.2, and Exhibit 10.3.

 

Item 9.01. Financial Statements and Exhibits.

 

Set forth below is a list of Exhibits included as part of this Current Report.

 

Exhibit No.   Description
10.1*   Employment Agreement, made and entered into as of May 1, 2023, by and between Dominari Holdings Inc. and Matthew B. McCullough
10.2*   Loan Agreement, made and entered into as of May 1, 2023, by and between Dominari Holdings Inc. and Matthew B. McCullough
10.3*   Bonus Agreement, made and entered into as of May 1, 2023, by and between Dominari Holdings Inc. and Matthew B. McCullough
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 5, 2023 DOMINARI HOLDINGS INC.
     
  By:

/s/ Anthony Hayes

  Name:  Anthony Hayes
  Title: Chief Executive Officer

 

  

3

 

 

Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Alkido Pharma Charts.
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Alkido Pharma Charts.